Reducing Returns from Online Shopping with Augmented Reality

 

Almost any good or service can be provided online in today’s day and age. You can do just about anything, from browsing and ordering clothing online to ordering groceries on an app and having them delivered to your home. But when it comes to retail shopping for clothing items, how will you know if something truly fits and that you will like?

There’s no surefire way to tell unless you physically try it on, right? Wrong! Now, retailers are utilizing technology so that consumers won’t even have to step foot in a store to know whether or not an item will fit and how it will look on them. Shopify has found this to be an effective strategy, reporting a reduction in returns by 40 percent. 

You might wonder how augmented reality can be effective in retail and how and why it works. 

On today’s episode of Relevant Solutions, Host Christine Russo speaks with Vadim Rogovskiy, CEO at 3D LOOK, to discuss how augmented reality penetrates and transforms the retail industry and eliminates the number of returns.  

Rogovskiy explained the accuracy of augmented reality in retail compared to traditionally used techniques: “With technology, we finally can measure human bodies super precisely, super quickly with just two images, and believe it or not, it’s often more accurate than what you can expect from professional tailors.” 

Russo and Rogovskiy also discussed… 

  • Why the market wasn’t ready for this augmented reality in the 1990s 
  • How the augmented reality can accommodate varying consumer preferences in clothing fit 
  • How body habits and fits differ from one state to another and how this has influenced sizing charts 

Rogovskiy explained how augmented reality is not just transformative for consumers but is also efficient for supply chains. “Ultimately, the retailers need to understand how their consumers actually look, what are their body shapes, those different locations, and what are the correlations between their body shapes and what they buy, what they keep, what they return…and so they can incorporate this intelligence into their supply chain,” he said. 

Rogovskiy is the founder of three businesses—AdCenter, Clikky, and 3DLOOK. He is currently CEO of 3DLOOK. Rogovskiy is also a Geek Ventures partner, a New York Angels investing community member, a mentor for 500 Startups, and a Contributor at Forbes Technology Council. He has a Master’s Degree in Management of Organizations from Odesa I.I.Mechnikov National University. 

Follow us on social media for the latest updates in B2B!

Image

Latest

cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More
organoids
Growing the Future of Cancer Research: Inside the Promise of Organoids
April 19, 2025

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…

Read More
Immuno-Oncology
Shaping the Future of Cancer Care Through Immuno-Oncology
April 19, 2025

In the ever-evolving world of cancer treatment, immuno-oncology (IO) continues to stand at the forefront of innovation. With recent FDA approvals for TIL therapies and bispecific antibodies, and new developments in CAR-T technologies, the field is rapidly expanding into combination-based strategies that integrate with standard care. Researchers are also exploring how to overcome challenges posed…

Read More